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A previously undescribed genetic site (sac-3) affecting susceptibility of the
gonococcus to normal human serum was localized on the gonococcal chromo-
some. The presence of the sac-3+ allele in a clinical isolate (FA889) resulted in
sensitivity only to relatively high concentrations of serum (.12.5%). Genetic
mapping experiments demonstrated that sac-3+ was tightly linked to another
genetic site (sac-l+) involved in determining susceptibility to normal human
serum and to a locus (nmp-3) involved in the replacement of outer membrane
protein I. The sac-l + and sac-3+ loci resulted in phenotypically distinct levels of
sensitivity to human serum. The sac-3+ serum sensitivity and sac-l+ serum
sensitivity loci recombined with high frequency, resulting in serum resistance.
The results show that serum sensitivity in clinical isolates may be due to different
serum sensitivity loci and suggest that different antigens and immunological
mechanisms could be responsible for sensitivity of different gonococcal isolates to
human serum.
Gonococci isolated from patients with dissem-
inated gonococcal infections are almost always
resistant to the bactericidal activity of normal
human serum (NHS) (6, 17). Conversely, strains
isolated from patients with uncomplicated gono-
coccal infections are often serum sensitive (1).
The uniform ability of strains causing dissemi-
nated gonococcal infection to evade this host
defense mechanism suggest that serum resist-
ance contributes to gonococcemia. A number of
reports have suggested that certain outer mem-
brane alterations involving lipopolysaccharide
(LPS) (7, 8, 11), protein I (10), and colony
opacity-related protein II species (13) may con-
tribute to susceptibility of the gonococcus to
NHS. However, despite considerable analysis,
the precise mechanisms of serum resistance are
poorly understood.
Hildebrandt et al. (10) reported that genetic
transformation of a serum-sensitive strain to
serum resistance resulted in the concomitant
transfer of a locus involved in the synthesis of
the protein I species characteristic of the serum-
resistant donor. Using different donors and re-
cipients in similar genetic experiments, Guymon
et al. (8) and Cannon et al. (3) were able to
genetically separate a locus involved in serum
resistance (sac-i) from a locus involved in re-
placement of the protein I species (nmp-2). Both
sac-i and nmp-2 mapped adjacent to genes in-
volved in ribosomal structure (streptomycin and
spectinomycin resistance) (19) and were there-
fore amenable to genetic analysis. Recently,
Spratt et al. (20) reported a second locus (sac-2)
involved in determination of resistance to se-
rum. This locus, however, is apparently weakly
linked to a locus involved in spectinomycin
resistance and results in only minor changes in
sensitivity to our lots ofNHS (Shafer and Spar-
ling, unpublished data).
In this communication we describe an addi-
tional site affecting the response of gonococci to
NHS. This site (sac-3) was phenotypically dis-
tinct from and genetically separable from sac-i
but was closely linked to sac-i and an nmp
locus.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains
of Neisseria gonorrhoeae used and their genetic con-
struction and relevant properties are listed in Table 1.
In accordance with recent publications (3, 20) dealing
with the genetics of serum sensitivity in the gonococ-
cus, we refer to loci dictating sensitivity as either sac-
I+ or sac-3+ (sac: serum-antibody-complement), and
the resistant alleles are termed sac-I or sac-3. Serum-
resistant strain FA19 and serum-sensitive strain F62
(sac-l +) have been well characterized previously (2, 3,
19). Strain FA628 is a sac-l' transformant of FA19.
Strain FA889 (sac-3+) is a recent clinical isolate ob-
tained from Inga Lind at the Statens Serum-Institut,
Copenhagen; its novel serum-sensitive phenotype
prompted this study. Strain FA899 is a sac-3+ trans-
formant of FA19. Strains FA628 and FA899 are thus
approximately isogenic except for their sac loci. Gon-
ococci were routinely passed on GCB agar (19) as
single-colony isolates. Colonies were carefully select-
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TABLE 1. Strains of N. gonorrhoeae used
Strain Relevant genotype Relevant phenotype Source
FA19 str-7+ spc4+ sac-I sac-3 Str5 Spc' Sacra A. Reyn
F62 str-7+ spc4+ sac-l+ sac-3 Str5 Spc' Sac' D. Kellogg
FA889 str-7+ spc4b sac-i sac-3+ Str5 Spcr Sacs I. Lind
FA899 str-7+ spc4 sac-I sac-3+ Str5 Spcr Sacs Spcr, Sac' transformant; FA889 x FA19
FA835 str48 spc4+ sac-i sac-3 Strf Spc' Sacr FA19 spontaneous Strr
FA101 str-7b spc4+ sac-i sac-3 Strr SpcS Sacr Previously described (19)
FA610 str-7 spc-4+ sac-l+ sac-3 Strr SpcS Sacs Str transformant; FA101 x F62
FA628 str-7 spc4+ sac-l+ sac-3 Strr Spc' Sacs Strr Sacs transformant; FA610 x FA19
FA942 str-7 spc-4 sac-i sac-3 Strf Spcr SaCr Spcr Sacr transformant; FA899 x FA628
FA950 str-7 spc4 sac-l+ sac-3 Strr Spc' Sacs Spcr transformant; FA899 x FA628
FA951 str-8 spc-4+ sac-i sac-3+ Strf Spc' Sacs StrT, Spc' transformant; FA835 x FA899
a Serum-resistant strains are designated Sacr, and serum-sensitive strains are designated Sac'.
b spc4 is a locus for spectinomycin resistance, and str-7 and str-8 are loci for streptomycin resistance.
ed for both the degree of piliation and opacity by the
criteria of Swanson (21).
Genetic transformation. Transforming DNA used in
genetic mapping experiments generally was prepared
by the method of Marmur (15), but in some experi-
ments (when indicated) crude DNA was prepared by
sodium dodecyl sulfate (SDS) lysis of whole gonococci
(19). These DNA preparations were used to transform
appropriate recipient strains as described by Sparling
et al. (19). In general, limiting concentrations (0.01 ,ug/
ml) ofDNA were used. Antibiotic-resistant transform-
ants were selected with GCB agar overlays (19) which
FIG. 1. Kinetic killing of strains of N. gonorrhoeae
by NHS. Sensitivity of NHS was determined as de-
scribed in the text with a 25% final concentration of
NHS. Symbols: A, strain FA19; N, strain FA889 (sac-
3+); *, strain F62 (sac-l+); 0, strain FA628 (sac-l+
transformant of FA19, from donor F62); 0, strain
FA899 (sac-3+ transformant of FA19, from donor
FA889).
contained either spectinomycin or streptomycin to
provide a final concentration of 200 Fg/ml. Transform-
ants were scored on GCB agar plates containing 200
pLg of either spectinomycin or streptomycin per ml.
Determination of sensitivity to NHS. Pooled NHS
was obtained from 6 to 10 laboratory volunteers deny-
ing any previous gonococcal infections and stored as
1-ml samples at -70°C. Thawed NHS was used once
in a bactericidal assay, and the remainder was discard-
ed. A modification of the microtiter dilution method of
Eisenstein et al. (6) was used to score for sensitivity to
pooled NHS. Serum dilutions employed were 1/2, 1/6,
1/18, and 1/54. Serum sensitivity was defined as a 70o
reduction in colony-forming units after a 45-min expo-
sure to serum at 37°C. The kinetics and extent of
killing of selected transformants were studied by ex-
posing 106 colony-forming units of gonococci per ml to
NHS at 37°C in Davis A Minimal Medium (Difco
Laboratories) supplemented with bovine serum albu-
min (final concentration of 0.5%). The final concentra-
tion of NHS used in most experiments was 25%.
Controls consisted of incubating the appropriate test
strains in Davis A media and bovine serum albumin
without NHS and in 25% NHS that had been inactivat-
ed by heating at 56°C for 30 min. Viability was
determined at appropriate intervals by dilution plating
onto GCB agar. All plates were incubated for 48 h at
37°C under 5% CO2.
Electrophoretic analysis of outer membrane proteins.
SDS-polyacrylamide gel electrophoresis of either lithi-
um acetate-extracted outer membrane vesicles (9) or
lysates of whole gonococci (2) was performed accord-
ing to Shapiro et al. (18). Gels were stained and
destained as previously described (2).
RESULTS
The degree of serum sensitivity of the gono-
coccal strains studied differed in the microtiter
assay and the bactericidal kinetic assay, depend-
ing on the dilution of NHS employed. At con-
centrations of at least 25% NHS, FA889, F62,
and FA628 were equally serum sensitive (Fig.
1). However, in the microtiter assay, clinical
isolate FA889 was resistant to dilutions of NHS
(greater than 1/6) at which strains F62 and
FA628 remained sensitive. The difference in the
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degree of serum sensitivity was quantitated by
exposing FA889, F62, and FA628 to several
concentrations ofNHS and determining viability
after incubation at 37°C for 45 min. Strains F62
and FA628 (each sac-i') were sensitive to 3%
NHS, whereas FA889 (sac-3+) required at least
12.5% NHS for bactericidal activity (data not
shown).
The observation that FA889 differed from F62
and FA628 in the concentration ofNHS required
for expression of serum sensitivity prompted an
examination of the genetics of serum sensitivity
in FA889. This was accomplished initially by
introducing the sac-3+ (serum-sensitive) locus in
FA889 into FA19, which is resistant to all con-
centrations of NHS (Fig. 1). FA19 has been the
subject of extensive previous genetic analysis in
this laboratory (2, 3, 19). SDS-prepared trans-
forming DNA from spectinomycin-resistant
(Spcr), serum-sensitive (Sacs) FA889 was used
to transform spectinomycin-sensitive (Spc'), se-
rum-resistant (Sac') FA19. Spcr transformants
were scored for Sacs by the microtiter dilution
method. Of 20 Spcr transformants, 12 (60%)
exhibited the Sacs phenotype of donor strain
FA889. This suggested that the sac-3+ locus
responsible for serum sensitivity in FA889 was
in the same general region of the chromosome as
the previously described sac-i locus (3). How-







FIG. 2. Effect of serum concentration of bacteri-
cidal activity against strains FA899 (sac-3 ) and
FA628 (sac-l+). NHS was diluted in Davis A media
supplemented with 0.5% bovine serum albumin. Cells
were incubated at 37°C, and the extent of killing was
determined after 45 min. Symbols: 0, FA628; 0,
FA899. At concentrations of NHS >3% the percent
survival of FA628 was <0.01%, whereas at concentra-
tions of NHS >12.5% the percent survival of FA899
was <0.01%.
and FA899, respectively) transformants differed
markedly in their sensitivity to low concentra-
tions of NHS (Fig. 2).
Isogenic gonococci can exhibit different colo-
nial opacity, and opaque colonies differ bio-
chemically from transparent colonies by the
presence of certain heat-modifiable outer mem-
brane proteins (13, 21, 22). Opaque and trans-
parent variants also may differ in susceptibility
to NHS (13). We tested transparent and opaque
variants of FA889 and FA899 but found no
differences in serum sensitivity (data not
shown).
The protein composition of lithium acetate-
extracted outer membrane vesicles of FA19
FA889, and FA899 was examined by SDS-poly-
acrylamide gel electrophoresis to determine
whether the presence of a certain species of
protein I was correlated with the acquisition of
serum sensitivity. Membrane vesicles were pre-
pared from nonpiliated, transparent colonies.
All three strains exhibited a similar protein pro-
file, except for the apparent molecular weight of
protein I (data not presented). The protein I of
FA19 migrated at an apparent molecular weight
of 36,500 (36.5K), whereas protein I of FA889
was about 39K. The 36.5K protein I species was
absent from preparations of FA899, and instead,
a new protein species of 39K was present. These
results suggested that the sac-3+ locus was
linked to a gene (nmp-3) affecting synthesis or
insertion of protein I.
A series of genetic crosses were performed to
determine the order and degree of linkage of sac-
3+ to the str, spc, and nmp loci in FA899. These
loci are known to be linked in the order str-spc-
nmp in FA19 (2). DNA prepared from strain
FA101 (Strr Spc' Sacr protein I36.5K) was used to
transform strain FA899 (Str' Spcr Sacs protein
I39K) to Strr. In a reciprocal cross, donor DNA
from FA899 was used to transform strain FA101
to Spcr. Transformants were purified on GCB
agar plates supplemented with either spectino-
mycin or streptomycin. Fifty transformants
from each cross were scored for resistance to
spectinomycin, streptomycin, and NHS and also
for protein I molecular weight by SDS-poly-
acrylamide gel electrophoresis of lysates of
whole cells. The results are summarized in Table
2. Analysis of the recombinant classes in the
first cross (FA101 x FA899) revealed that acqui-
sition of the donor's protein I species always
occurred when the recipient acquired the do-
nor's Sacr property. These data, and others not
presented, indicated that the sac-3+ (Sacs) locus
in FA899 was located to the right (in the conven-
tion used) of the spc4 locus, close to the locus
nmp-3 which affects protein I. In the reciprocal
cross (FA899 x FA101) 82% (14/17) of the Spcr
transformants which acquired the donor's pro-
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TABLE 2. Locus sac-3+ for serum sensitivity in FA899 closely linked to, but separable from, locus nmp-3
affecting protein I
Cross (donor x recipient)a Recombinant classes obtained Frequency of isolation (%)b
A. FA101 x FA899C Strr Spcr Sacs protein I39K 38 (76)
Strr SpcS Sacs protein I39K 6 (12)
Strr Spc' Sacr protein I36.5K 4 (8)
Strr Spc' Sacr protein I36.5K 2 (4)
B. FA899 x FAlOld Spcr Sacr protein I36.5K 31 (62)
Spcr Sacs protein I39K 14 (28)
SpCr Sac' protein I36.5K 2 (4)
SpCr Sacr protein I39K 3 (6)
a The phenotype of strain FA101 is Strr Spc' Sacr protein I36.5K. and the phenotype of strain FA899 is Str5 Spcr
Sacs protein I39K*
b As a percentage of 50 transformants scored.
c For cross A, the selected marker was Strr, and 50 transformants were scored. Of the 50, 50 (100o) scored for
Str, 10 (20%) scored for Spc', 6 (12%) scored for Sacr, and 6 (12%) scored for protein I36.5K.
d For cross B, the selected marker was Spcr, and 50 transformants were scored. Of the 50, 12 (24%) scored for
Str5, 50 (100%6) scored for Spcr, 16 (32%) scored for Sacs, and 17 (34%) scored for protein I39K.
tein I species also acquired the donor's Sacs
phenotype, whereas 4% (2/50) of the Spcr trans-
formants acquired the donor's Sacs phenotype
but retained the recipient's protein I species
(Table 2). Thus, sac-3 was closely linked to, but
separable from, nmp-3.
These results are very similar to those report-
ed earlier for the sac-I+ locus by Cannon et al.
(3). However, the phenotypic differences in the
levels of sensitivity to NHS between sac-l+ and
sac-3+ transformants (Fig. 2) suggested that the
sac-i+ and sac-3+ loci were not identical. Ex-
periments were therefore undertaken to deter-
mine whether genetic crosses between approxi-
mately isogenic serum-sensitive donors and
recipients which differed in their sac-i and sac-3
loci might result in recovery of serum-resistant
recombinants.
DNA from Sacs FA899 (str-7+ spc-4 sac-3+)
was used to transform Sacs FA628 (str-7 spc4+
sac-i') to Spcr. We reasoned that if sac-i+ and
sac-3+ were separate genes, crossovers between
sac-3+ and sac-i+ should occur frequently, re-
sulting in serum resistance. If they were alleles
of a single gene, crossovers probably would be
relatively rare, and serum-resistant recombi-
nants should be uncommon. Among 20 Spcr
transformants scored for Sacr by the microtiter
dilution assay, 6 (30%) were Sacr. The kinetics
of bactericidal activity of NHS for one of these
Sacr transformants (FA942) was determined
(Fig. 3). After exposure to 25% NHS, recombi-
nant strain FA942 was at least 1,000-fold more
serum resistant than parental strains FA899 and
FA628, although it was not quite as serum
resistant as FA19. In the reciprocal cross be-
tween these Sacs strains (donor FA628 x recipi-
ent FA899), Strf transformants were recovered
which displayed the Sac' phenotype of either
strain FA942 or FA19 (data not shown). In
addition, recombinants of recipient strain FA899
were obtained which were as serum sensitive as
donor strain FA628 (data not shown). The ability
to recover transformants with either increased
serum resistance or increased serum sensitivity
in reciprocal crosses between Sacs strains con-








QO IL i15 30 45MINUTES EXPOSED TO NHS
FIG. 3. Serum resistance of a recombinant ob-
tained from a cross between two serum-sensitive
strains. Sensitivity of NHS was determined as de-
scribed in the text with a 25% final concentration of
NHS. Symbols: A, strain FA19; 0, strain FA628; *,
strain FA899; *, strain FA942 (FA628 Sac' transform-
ant with donor DNA from FA899). The values report-
ed are the average of four experiments.
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Additional experiments were performed to
map more precisely the sac-i + and sac-3+ sites
with respect to spc4. In the first case, donor
DNA from FA899 (spc4 sac-i sac-3+) was used
to transform FA628 (spc4+ sac-i+ sac-3) to
Spcr. Among Spcr transformants, 26% (36/135)
were sac-i sac-3 (Sac'). In a reciprocal cross,
donor DNA from FA950 (spc4 sac-i+ sac-3)
was introduced into recipient strain FA951 (spc-
4+ sac-i sac-3+). Among Spcr transformants,
only 5.2% (6/116) were sac-i sac-3 (Sac'). The
differences in frequencies of Sacr recombinants
in the two experiments presumably were due to
the greater frequency of recombinants requiring
a double, as opposed to a quadruple, crossover
event and indicated a probable gene order of
spc4-sac-1-sac-3.
DISCUSSION
The ability of certain gonococcal strains to
resist killing by NHS has been correlated with
virulence. Consequently, the Sacr phenotype
has become the subject of considerable interest.
Unfortunately the antigen(s) on the gonococcus
which is a target for killing by antibodies and
complement in NHS remains to be elucidated. It
is quite possible that killing by NHS is a com-
plex event and that multiple cell surface antigens
may be involved. To date, three loci (sac-i, sac-
2, and. sac-3) have been shown to govern the
level of serum resistance in clinical isolates (3,
20; this study). Presumably, the expression of
these loci modifies cell envelope structure in
some fashion, permitting the strain to evade the
bactericidal activity of NHS. In addition, mu-
tants of strain FA19 with altered core LPS
structure and increased sensitivity to NHS have
been isolated; these are genetically and bio-
chemically distinct from the sac loci described
here (7).
The results presented in this communication
show that the serum sensitivity loci in strains
F62 (sac-] +) and FA889 (sac-3+) are at different
sites and that they confer phenotypically distinc-
tive levels of serum sensitivity. They also show
that sac-l and sac-3+ are linked on the gono-
coccal chromosome, since each is linked closely
to nmp-3 and less closely to spc4. It is possible
that sac-i + and sac-3+ are different genes, since
we easily obtained sac-i sac-3 (Sac') recombi-
nants in crosses between sac-i sac-3+ (Sacs) and
sac-i+ sac-3 (Sacs) parental strains. If such
recombinants arose because of an intragenic
crossover (i.e., sac-P and sac-3+ are different
sites in a single gene), such intragenic recombi-
nation occurred at a frequency of 30% when a
linked distal marker (spc4) was selected; the
absolute recombination frequency may have
been higher. Unfortunately, difficulties in direct
selection of Sacr recombinants prevented deter-
mination of a recombination index. Whether
sac-i+ and sac-3+ are different genes can only
be determined with confidence by complementa-
tion analysis (not yet possible in gonococci) or
by identifying the gene products which result
from the expression of these genes.
To date, no chemical evidence has been found
to indicate that an outer membrane protein is
affected by sac-3+. Preliminary gas chromatog-
raphy analysis of alditol acetate derivatives of
LPS isolated from FA899 and an additional sac-
3+ transformant of FA19 (FA940) suggests that
sac-3+ does not grossly affect LPS chemotype.
The LPSs of FA19, FA899, and FA940 are
nearly identical but are distinct from the LPS of
FA889. The galactose/glucose ratio of FA889
LPS is approximately 2.5, whereas that of FA19,
FA899, and FA940 is approximately 1.5. More
detailed analysis of the LPS from these strains is
currently under investigation.
Our results show that Sacr strain FA19 con-
tains at least two closely linked sites (sac-i and
sac-3) involved in determining resistance to
NHS. If sac-i and sac-3 are mutations of sepa-
rate genes, strains such as F62 or FA628 (sac-l +
sac-3) and FA889 or FA899 (sac-i sac-3+)
carry serum resistance mutations which are not
expressed phenotypically (i.e., sensitivity to
NHS is dominant over resistance). Dominance
of genes for sensitivity to NHS would probably
result if different antigens on the gonococcal cell
surface can interact with different batericidal
antibody species; resistance of NHS would only
result if there were no, or critically few, antigen-
ic sites capable of reacting with bactericidal
antibody or complement or both.
In this and earlier communications (3, 20), loci
identified as determining serum sensitivity have
been designated as the wild-type alleles, i.e.,
sac-i', sac-2+, and sac-3+. This designation is
arbitrary. One might argue that loci dictating
serum resistance should be designated as the
wild-type alleles since the majority of gonococ-
cal isolates are Sacr (6, 17). The preponderance
of gonococcal isolates which are Sacr, however,
might be due to selection in vivo of spontaneous
Sacr mutants. Since the genetic data suggest that
multiple genes are required for serum resistance,
several mutational events would have to occur
to generate spontaneous Sacr clones. At first
glance this might seem improbable. However,
many gonococcal isolates are multiple auxo-
trophs (4, 12), which presumably resulted from
spontaneous mutations at separate loci (4, 16).
Moreover, Catlin and Nash (5) have described
clinical isolates of the gonococcus with muta-
tions in different loci which result in arginine
auxotrophy. Based on these precedents and the
known ability of gonococci to spontaneously
alter cell surface structures (7, 13, 14, 21, 22), it
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is quite possible that pressures of environmental
selection resulted in the appearance of spontane-
ous Sacr clones.
The difference in susceptibility ofNHS of sac-
I+ sac-3 or sac-i sac-3+ strains (Fig. 2) might
influence the virulence of such strains. Strains
such as FA889 which are only susceptible to
relatively high concentrations of NHS might
evade killing at sites where the relative concen-
tration of bactericidal antibody-complement is
diminished. The clinical significance of this ob-
servation is unknown, in part because of lack of
information about the types and quantities of
bactericidal components on genital mucosal sur-
faces.
In conclusion, our results indicate that FA19
contains at least two closely linked sites (sac-i
and sac-3) involved in serum resistance. It is
possible that multiple genes are involved in the
determination of resistance of gonococci to
NHS; different immunological mechanisms may
be involved in the killing of different gonococci
by serum. Additionally, the results obtained in
this investigation and others (2, 3) suggest that
the gonococcal chromosome contains a se-
quence of closely linked genes (sac-i, sac-3,
nmp, penB) known or presumed to affect cell
envelope structure. These loci may be important
in determining virulence.
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